Hi-Great Group Holding CoOver The Counter Market:HIGR
- LAST PRICE0.0178
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0178
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Hi-Great Group Holding Co | 1.8M | 148.3x | --- |
Fresh2 Group Ltd | 14.7M | -0.1x | --- |
Aclarion Inc | 2.1M | 0.0x | --- |
Herborium Group Inc | 1.1M | 0.0x | --- |
Regen BioPharma Inc | 2.8M | -2.1x | --- |
Qualigen Therapeutics Inc | 1.9M | -0.1x | --- |
Company Information
Hi-Great Group Holding Company holds a license agreement for New Business Plan with the KRAS gene, which is among the most frequently mutated genes across all cancers, including pancreatic, lung, and colorectal. The Company is engaged in marketing, selling, and distributing SellaCare, Inc's organic longevity health supplement. The Company is in license agreement with SellaCare, Inc. in the areas of longevity and additional health benefits and it also expands into the cosmetic sector as an overall sustainable revenue platform.
Contact Information
- Headquarters
- 621 S. Virgil Ave #470LOS ANGELES, CA, United States 90005
- Phone
- 213-219-7746
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer
- Ho Yang Jun
- Chief Financial Officer, Treasurer
- Soon Yang Ho
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.8M |
|---|---|
Revenue (TTM) | $148.8K |
Shares Outstanding | 100.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | 148.3x |
Price/Sales (TTM) | 12.0 |
Price/Cash Flow (TTM) | 25.2x |
Operating Margin | 8.16% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
